NCT05961735

Brief Summary

In this study, PECS II block or CSAB will be applied to patients who have had a modified radical mastectomy under general anesthesia for postoperative pain relief by using 30 ml of 0.25% bupivacaine .All patients will receive tramadol with a patient-controlled analgesia device during the postoperative period. Pain, nausea-vomiting, additional analgesic and antiemetic drug requirement, within 24 hours postoperatively will be compared between groups. In this study, it was aimed to compare the efficacy of both peripheral nerve block methods in patients after mastectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

3 months

First QC Date

July 14, 2023

Last Update Submit

April 10, 2025

Conditions

Keywords

PECS II BlockCombined Serratus Anterior Plane BlockMastectomy

Outcome Measures

Primary Outcomes (7)

  • Pain on the Numeric Rating Scale (NRS)

    Participants recorded pain rated on the numeric rating scale (NRS) at 6 time points. NRS range was from 0-10 with 0 being no pain and 10 the worst pain possible.

    0 hours postoperatively

  • Pain on the Numeric Rating Scale (NRS)

    Participants recorded pain rated on the numeric rating scale (NRS) at 6 time points. NRS range was from 0-10 with 0 being no pain and 10 the worst pain possible.

    2 hours postoperatively

  • Pain on the Numeric Rating Scale (NRS)

    Participants recorded pain rated on the numeric rating scale (NRS) at 6 time points. NRS range was from 0-10 with 0 being no pain and 10 the worst pain possible.

    4 hours postoperatively

  • Pain on the Numeric Rating Scale (NRS)

    Participants recorded pain rated on the numeric rating scale (NRS) at 6 time points. NRS range was from 0-10 with 0 being no pain and 10 the worst pain possible.

    8 hours postoperatively

  • Pain on the Numeric Rating Scale (NRS)

    Participants recorded pain rated on the numeric rating scale (NRS) at 6 time points. NRS range was from 0-10 with 0 being no pain and 10 the worst pain possible.

    12 hours postoperatively

  • Pain on the Numeric Rating Scale (NRS)

    Participants recorded pain rated on the numeric rating scale (NRS) at 6 time points. NRS range was from 0-10 with 0 being no pain and 10 the worst pain possible.

    24 hours postoperatively

  • Total opioid consumption

    All patients will receive tramadol with a patient-controlled analgesia device during the postoperative period.

    24 hours postoperatively

Study Arms (2)

Patients with PECS II Block

PECS 2 block will be applied to patients in this group.

Other: PECS II Block

Patients with Combined Serratus Anterior Plane Block

Combined Serratus Anterior Plane Block will be applied to patients in this group.

Other: Combined Serratus Anterior Plane Block

Interventions

The Pecs II block is applied to the patients after induction of anesthesia .

Patients with PECS II Block

Combined Serratus Anterior Plane Block is applied to the patients after induction of anesthesia .

Patients with Combined Serratus Anterior Plane Block

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients who undergone mastectomy surgery

You may qualify if:

  • Patients between the ages of 18-80
  • Patients with ASA score I-II-III
  • Patients with a body mass index (BMI) between 18 and 40
  • Patients who underwent PECS-II block or CSAB with mastectomy in the operating room

You may not qualify if:

  • Patients under the age of 18 and over the age of 80
  • Patients with an ASA score of IV and above
  • Patients with advanced co-morbidity
  • Patients with a history of bleeding diathesis
  • Patients who have infection in the area which is to be blocked
  • BMI below 18 and over 40
  • Patients undergoing emergency surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Varlık Mahallesi, Halil Sezai Erkut Caddesi Yenimahalle, 06170, Turkey (Türkiye)

Location

Related Publications (3)

  • Maranto CJ, Strickland NR, Goree JH. Combined Superficial and Deep Serratus Plane Block With Bupivacaine, Dexamethasone, and Clonidine in the Treatment of a Patient With Postmastectomy Pain Syndrome: A Case Report. A A Pract. 2018 Nov 1;11(9):236-237. doi: 10.1213/XAA.0000000000000792.

  • Zhao J, Han F, Yang Y, Li H, Li Z. Pectoral nerve block in anesthesia for modified radical mastectomy: A meta-analysis based on randomized controlled trials. Medicine (Baltimore). 2019 May;98(18):e15423. doi: 10.1097/MD.0000000000015423.

  • Grape S, Jaunin E, El-Boghdadly K, Chan V, Albrecht E. Analgesic efficacy of PECS and serratus plane blocks after breast surgery: A systematic review, meta-analysis and trial sequential analysis. J Clin Anesth. 2020 Aug;63:109744. doi: 10.1016/j.jclinane.2020.109744. Epub 2020 Feb 25.

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Yusuf Ozguner

    Ankara Etlik City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 14, 2023

First Posted

July 27, 2023

Study Start

August 1, 2023

Primary Completion

November 1, 2023

Study Completion

June 1, 2024

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations